114 related articles for article (PubMed ID: 25093538)
1. Total synthesis and conformational analysis of apratoxin C.
Masuda Y; Suzuki J; Onda Y; Fujino Y; Yoshida M; Doi T
J Org Chem; 2014 Sep; 79(17):8000-9. PubMed ID: 25093538
[TBL] [Abstract][Full Text] [Related]
2. Potent oxazoline analog of apratoxin C: Synthesis, biological evaluation, and conformational analysis.
Yoshida M; Onda Y; Masuda Y; Doi T
Biopolymers; 2016 Nov; 106(4):404-14. PubMed ID: 26584466
[TBL] [Abstract][Full Text] [Related]
3. Conformation-Based Design and Synthesis of Apratoxin A Mimetics Modified at the α,β-Unsaturated Thiazoline Moiety.
Onda Y; Masuda Y; Yoshida M; Doi T
J Med Chem; 2017 Aug; 60(15):6751-6765. PubMed ID: 28682609
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities.
Ma D; Zou B; Cai G; Hu X; Liu JO
Chemistry; 2006 Oct; 12(29):7615-26. PubMed ID: 16832801
[TBL] [Abstract][Full Text] [Related]
5. Solid-phase total synthesis of (-)-apratoxin A and its analogues and their biological evaluation.
Doi T; Numajiri Y; Takahashi T; Takagi M; Shin-ya K
Chem Asian J; 2011 Jan; 6(1):180-8. PubMed ID: 21080404
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of the biologically active natural product cyclodepsipeptides apratoxin A and its analogues.
Doi T
Chem Pharm Bull (Tokyo); 2014; 62(8):735-43. PubMed ID: 25087625
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric total synthesis of apratoxin D.
Robertson BD; Wengryniuk SE; Coltart DM
Org Lett; 2012 Oct; 14(20):5192-5. PubMed ID: 23057680
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of (-)-apratoxin A, 34-epimer, and its oxazoline analogue.
Numajiri Y; Takahashi T; Doi T
Chem Asian J; 2009 Jan; 4(1):111-25. PubMed ID: 19034894
[TBL] [Abstract][Full Text] [Related]
9. Dolastatin 11 conformations, analogues and pharmacophore.
Ali MA; Bates RB; Crane ZD; Dicus CW; Gramme MR; Hamel E; Marcischak J; Martinez DS; McClure KJ; Nakkiew P; Pettit GR; Stessman CC; Sufi BA; Yarick GV
Bioorg Med Chem; 2005 Jul; 13(13):4138-52. PubMed ID: 15878670
[TBL] [Abstract][Full Text] [Related]
10. Divergent Synthesis of Revised Apratoxin E, 30-epi-Apratoxin E, and 30S/30R-Oxoapratoxin E.
Mao ZY; Si CM; Liu YW; Dong HQ; Wei BG; Lin GQ
J Org Chem; 2017 Oct; 82(20):10830-10845. PubMed ID: 28933840
[TBL] [Abstract][Full Text] [Related]
11. Total synthesis of the marine cyanobacterial cyclodepsipeptide apratoxin A.
Chen J; Forsyth CJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12067-72. PubMed ID: 15231999
[TBL] [Abstract][Full Text] [Related]
12. Apratoxin D, a potent cytotoxic cyclodepsipeptide from papua new guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida.
Gutiérrez M; Suyama TL; Engene N; Wingerd JS; Matainaho T; Gerwick WH
J Nat Prod; 2008 Jun; 71(6):1099-103. PubMed ID: 18444683
[TBL] [Abstract][Full Text] [Related]
13. Total synthesis of apratoxin A.
Doi T; Numajiri Y; Munakata A; Takahashi T
Org Lett; 2006 Feb; 8(3):531-4. PubMed ID: 16435877
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic agents. 599. Total synthesis of dolastatin 16.
Pettit GR; Smith TH; Arce PM; Flahive EJ; Anderson CR; Chapuis JC; Xu JP; Groy TL; Belcher PE; Macdonald CB
J Nat Prod; 2015 Mar; 78(3):476-85. PubMed ID: 25689568
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Avallone E; Smith CD; Gomez-Paloma L; Riccio R
Bioorg Med Chem; 2005 Sep; 13(17):5225-39. PubMed ID: 16023351
[TBL] [Abstract][Full Text] [Related]
17. Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity.
Chen QY; Liu Y; Cai W; Luesch H
J Med Chem; 2014 Apr; 57(7):3011-29. PubMed ID: 24660812
[TBL] [Abstract][Full Text] [Related]
18. A functional genomics approach to the mode of action of apratoxin A.
Luesch H; Chanda SK; Raya RM; DeJesus PD; Orth AP; Walker JR; Izpisúa Belmonte JC; Schultz PG
Nat Chem Biol; 2006 Mar; 2(3):158-67. PubMed ID: 16474387
[TBL] [Abstract][Full Text] [Related]
19. Apratoxin H and apratoxin A sulfoxide from the Red Sea cyanobacterium Moorea producens.
Thornburg CC; Cowley ES; Sikorska J; Shaala LA; Ishmael JE; Youssef DT; McPhail KL
J Nat Prod; 2013 Sep; 76(9):1781-8. PubMed ID: 24016099
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.
Otrubova K; Lushington G; Vander Velde D; McGuire KL; McAlpine SR
J Med Chem; 2008 Feb; 51(3):530-44. PubMed ID: 18186604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
